MyAverix Finance
F · Healthcare
Outlook Therapeutics, Inc. (41O)
Biotechnology
Outlook Therapeutics, Inc. (41O) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 41O
Outlook Therapeutics, Inc. (41O) — FAQ
What is 41O's P/E ratio?
The price-to-earnings (P/E) ratio for Outlook Therapeutics, Inc. (41O) is 18.00 (data as of 2026-03-24).
Does Outlook Therapeutics, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Outlook Therapeutics, Inc. (41O). Check the MyAverix Finance app for the latest dividend data.
What sector is Outlook Therapeutics, Inc. in?
Outlook Therapeutics, Inc. (41O) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 41O listed on?
41O is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.